CIRSE Registry for SIR-Spheres in France (CIRT-FR)
NCT: NCT03256994 · COMPLETED
Brief Summary
Selective Internal Radiation Therapy (SIRT), also known as radioembolisation, is a minimal invasive, endovascular treatment for primary and secondary liver tumours. In France, SIR-Spheres are listed as reimbursable by the national health authorities (Haute Autorité de Santé \[HAS\]). In order to evaluate the reimbursement after five years, all patients treated with SIR-Spheres will be entered into a registry that collects data on the real-life clinical application of SIRT and reports to the national authorities.
Frequently Asked Questions
What is CIRSE Registry for SIR-Spheres in France (CIRT-FR)?
CIRSE Registry for SIR-Spheres in France (CIRT-FR) is a clinical trial registered under NCT03256994. Current status: COMPLETED.
What is the status of NCT03256994?
The current status of NCT03256994 (CIRSE Registry for SIR-Spheres in France (CIRT-FR)) is: COMPLETED.
When did CIRSE Registry for SIR-Spheres in France (CIRT-FR) start?
CIRSE Registry for SIR-Spheres in France (CIRT-FR) started on 2017-08-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.